Frohlich Tom
SEC insider (Form 3/4/5 filer). CIK 0001823925. Chief Executive Officer at Jade Biosciences, Inc. (JBIO). 2 reported Form 4/5 transactions since Sep 2024; latest on Feb 12, 2026. Located in WALTHAM, MA.
Companies Frohlich Tom has filed insider reports for
- Jade Biosciences, Inc. (JBIO): Director, Officer, Chief Executive Officer
Frohlich Tom
CIK: 0001823925
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
JBIO
Jade Biosciences, Inc.
DirectorOfficer